Cigna files reply for dismissing US monopolization claims over TRICARE program
( July 21, 2026, 03:06 GMT | Official Statement) -- MLex Summary: Cigna Group and its affiliates filed a reply in support of its motion to dismiss US claims accusing it of illegally rigging the market for the delivery of specialty prescription drugs, saying the opposition argues new, unpled theories that fail on their own terms. “To convert frustrations about coverage limitations into an antitrust case, plaintiffs make conclusory statements about what they assume are the terms of contracts between Express Scripts and its clients and speculate that their (unidentified) plan sponsors did not freely choose those terms. Stripped of these speculative and conclusory allegations, nothing remains of the Sherman Act claims at all,” Cigna argued.See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.